Bp PLC Gilead Sciences, Inc. Transaction History

Bp PLC

  • $13.2 Million
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$67.69 - $73.03 $1.92 Million - $2.08 Million
-28,423 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$63.47 - $69.35 $765,955 - $836,915
-12,068 Reduced 29.8%
28,423 $1.96 Million
Q1 2021

May 13, 2021
SELL
$60.0 - $68.46 $477,360 - $544,667
-7,956 Reduced 16.42%
40,491 $2.62 Million
Q4 2020

Feb 08, 2021
SELL
$56.65 - $64.55 $2.85 Million - $3.25 Million
-50,328 Reduced 50.95%
48,447 $2.82 Million
Q3 2020

Oct 30, 2020
SELL
$62.1 - $78.08 $1.63 Million - $2.05 Million
-26,225 Reduced 20.98%
98,775 $6.24 Million
Q2 2020

Aug 05, 2020
SELL
$72.34 - $84.0 $3.4 Million - $3.95 Million
-47,000 Reduced 27.33%
125,000 $9.62 Million
Q1 2020

May 05, 2020
BUY
$62.63 - $80.22 $2.82 Million - $3.61 Million
45,000 Added 35.43%
172,000 $12.8 Million
Q2 2019

Jul 29, 2019
SELL
$61.87 - $69.38 $247,480 - $277,520
-4,000 Reduced 3.05%
127,000 $8.58 Million
Q1 2019

May 08, 2019
SELL
$62.53 - $70.05 $125,060 - $140,100
-2,000 Reduced 1.5%
131,000 $8.52 Million
Q4 2018

Feb 06, 2019
SELL
$60.54 - $79.0 $1.7 Million - $2.21 Million
-28,000 Reduced 17.39%
133,000 $8.32 Million
Q3 2018

Nov 02, 2018
SELL
$71.28 - $78.92 $213,840 - $236,760
-3,000 Reduced 1.83%
161,000 $12.4 Million
Q2 2018

Jul 30, 2018
SELL
$64.88 - $75.68 $4.48 Million - $5.22 Million
-69,000 Reduced 29.61%
164,000 $11.6 Million
Q1 2018

Apr 26, 2018
BUY
$72.84 - $88.8 $3.5 Million - $4.26 Million
48,000 Added 25.95%
233,000 $17.6 Million
Q4 2017

Feb 06, 2018
SELL
$71.15 - $83.52 $3.42 Million - $4.01 Million
-48,000 Reduced 20.6%
185,000 $13.3 Million
Q3 2017

Oct 30, 2017
BUY
$72.11 - $85.47 $16.8 Million - $19.9 Million
233,000
233,000 $18.9 Million

Others Institutions Holding GILD

# of Institutions
1,924
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email